Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release by Nunan, Robert et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/59446/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Nunan, Robert, Sivasathiaseelan, Harri, Khan, Damla, Zaben, Malik J. A. and Gray, William Peter
2014. Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of
hippocampal precursor cells via IL-4 release. Glia 62 (8) , pp. 1313-1327. 10.1002/glia.22682 file 
Publishers page: http://dx.doi.org/10.1002/glia.22682 <http://dx.doi.org/10.1002/glia.22682>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
RESEARCH ARTICLE
Microglial VPAC1R Mediates a Novel
Mechanism of Neuroimmune-Modulation of
Hippocampal Precursor Cells Via IL-4
Release
Robert Nunan,1 Harri Sivasathiaseelan,1 Damla Khan,2 Malik Zaben,1,2 and William Gray1,2
Neurogenesis, the production of new neurons from neural stem/progenitor cells (NSPCs), occurs throughout adulthood in the
dentate gyrus of the hippocampus, where it supports learning and memory. The innate and adaptive immune systems are
increasingly recognized as important modulators of hippocampal neurogenesis under both physiological and pathological
conditions. However, the mechanisms by which the immune system regulates hippocampal neurogenesis are incompletely
understood. In particular, the role of microglia, the brains resident immune cell is complex, as they have been reported to
both positively and negatively regulate neurogenesis. Interestingly, neuronal activity can also regulate the function of the
immune system. Here, we show that depleting microglia from hippocampal cultures reduces NSPC survival and proliferation.
Furthermore, addition of purified hippocampal microglia, or their conditioned media, is trophic and proliferative to NSPCs.
VIP, a neuropeptide released by dentate gyrus interneurons, enhances the proliferative and pro-neurogenic effect of microglia
via the VPAC1 receptor. This VIP-induced enhancement is mediated by IL-4 release, which directly targets NSPCs. This dem-
onstrates a potential neuro-immuno-neurogenic pathway, disruption of which may have significant implications in conditions
where combined cognitive impairments, interneuron loss, and immune system activation occurs, such as temporal lobe epi-
lepsy and Alzheimer’s disease.
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Introduction
Postnatal and adult hippocampal neurogenesis support hip-pocampal dependent learning and memory under physio-
logical conditions (Dupret et al., 2007; Gould et al., 1999;
Leuner et al., 2006; Shors et al., 2001; Winocur et al., 2006;
Zhang et al., 2008). Furthermore, altered neurogenesis has
been implicated in cognitive and mood impairment in tem-
poral lobe epilepsy (Barkas et al., 2012; Kuruba et al., 2009),
depression, and certain neurodegenerative diseases (Jessberger
et al., 2007; Jin et al., 2004; Kempermann, 2002; Malberg
et al., 2000; Parent et al., 1997; Rockenstein et al., 2007),
suggesting that hippocampal neurogenesis may be an appro-
priate therapeutic target for these conditions. All these condi-
tions have an important neuroinflammatory component to
their pathogenesis, and the innate and adaptive immune sys-
tems are increasingly recognized as important control systems
for hippocampal neurogenesis under both physiological and
pathological conditions. However, the mechanisms by which
the immune system regulates hippocampal neurogenesis are
incompletely understood.
It is clear that in the stem cell niche there is a dynamic
interplay between neural stem/progenitor cells (NSPCs) and
microglial cells. Unchallenged microglia play an important
role in scavenging apoptotic precursors in the subgranular
zone niche (Sierra et al., 2010), and in vitro studies have
shown that TGFb released by scavenging microglia promotes
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stem cell/neuronal proliferation and survival (Battista et al.,
2006; Fadok et al., 1998). Microglia through either the
release of pro-inflammatory agents or neurotrophic factors
(IGF1, BDNF, etc.) can affect neurogenesis as well as neuro-
nal survival and function (Battista et al., 2006; Butovsky
et al., 2006; Cacci et al., 2008; Ekdahl et al., 2003; Ziv
et al., 2006). More recently, it has become apparent that neu-
rons themselves may control and regulate the immune activa-
tion and function, including microglia, either directly or
through mediators (Biber et al., 2007; McAllister and van de
Water, 2009; Pocock and Kettenmann, 2007; Zietlow et al.,
1999). Within the stem cell niche, GABA-ergic interneurons
are ideally placed to signal neuronal activity and to co-release
important peptide neurotransmitters such as NPY and VIP
into the surrounding microenvironment. Although GABA has
been shown to promote neuronal differentiation of NSPCs
and the integration of their progeny, we have previously
shown that NPY, co-released by GABA-ergic interneurons
under certain firing conditions, is a potent proliferative factor
for NSPCs in the postnatal and adult dentate (Howell et al.,
2003, 2005, 2007) and that Galanin is both proliferative and
trophic for neuronally committed precursors (Abbosh et al.,
2011). We have also shown that VIP through VPAC2 recep-
tor activation expands the pool of proliferating nestin-
expressing dentate NSPCs, by preventing either a neuronal or
glial fate choice and by separately supporting their survival,
while selective VPAC1 receptor activation promotes a neuro-
genic granule cell fate (Zaben et al., 2009).
Although VIP as a neurotransmitter is a direct regulator
of hippocampal neurogenesis (Zaben et al., 2009), it exerts a
wide spectrum of immunological functions controlling the
homeostasis of the immune system with a primary
anti-inflammatory role (Gomariz et al., 2001). In adaptive
immunity, VIP appears to inhibit cytokine production and
proliferation of T-lymphocytes, as well as inducing Th2 dif-
ferentiation of T-lymphocytes, rather that Th1 (Gonzalez-Rey
and Delgado, 2007; Gonzalez-Rey et al., 2007). In innate
immunity, VIP inhibits several macrophage functions, includ-
ing phagocytosis, respiratory burst, and chemotaxis as well as
LPS-induced production and release of pro-inflammatory
cytokines (IL6, TNFa, and IL12) and chemokines (Delgado
et al., 2003). Although it is clear that VIP reduces release of
inflammatory mediators that are detrimental to neurogenesis
from LPS-activated macrophages and microglia, the effect of
VIP on “unstimulated” microglia has not been elucidated.
The presence and release of VIP within the lymphoid micro-
environment and the existence of VIP receptors on immune
cells suggest that neuropeptides such as VIP are prime candi-
dates for being a mediator of neuro-immune interactions
(Ganea and Delgado, 2001). As microglia express neuropep-
tide receptors (Pocock and Kettenmann, 2007), it is possible
that this neuro-glial interaction is mediated by neuropeptides;
however, information regarding the effects of neuropeptides
on microglial activation is sparse and as a result the effects of
neuropeptides on microglial-derived cytokines, chemokines,
and neuroprotective factors are not fully understood.
To study the role of VIP as a component of the neuro-
immune modulation of hippocampal neurogenesis, we have
generated postnatal hippocampal neural stem cells (when den-
tate gyrus neurogenesis at its peak) and either co-cultured them
with pure hippocampal microglia or treated them with
microglia-conditioned medium in the presence or absence of
VIP. We show that depletion of microglia from cultures is asso-
ciated with reduced NSPC survival and proliferation, while co-
culturing of neural stem cells with microglia or treatment with
microglia conditioned medium enhances NSPC survival and
proliferation. We further demonstrate that treatment of NSPCs
with conditioned medium of microglia pre-exposed to VIP at
physiological concentrations significantly enhances the prolifer-
ative and trophic effect of microglia. These VIP-stimulated
microglia-mediated proliferative effects on NSPCs are mediated
via the release of the anti-inflammatory cytokine IL-4, as
blockade of IL-4 completely abolished the proliferative effects
of microglial VIP pre-conditioning. This study identifies the
neuropeptide VIP as an important neuro-immune modulator
in the control of hippocampal neurogenesis as well as empha-
sizing the role of microglia as an important member of the
neural stem cell niche.
Materials and Methods
Cell Culture
Postnatal rat hippocampal NSPC cultures were generated from post-
natal Wistar rat hippocampi (P7-10) as described elsewhere (Howell
et al., 2003). Briefly, under sterile techniques, hippocampi were
quickly dissected and sectioned on a MacIlwain tissue chopper into
400-lm-thick slices in GEY’s balanced salt solution (Life Technolo-
gies, Paisley, UK) supplemented with 4.5 mg/ml glucose at 4C.
The tissue slices were then digested with 2 mg/ml papain (22.0 U/
mg, Sigma) in pre-warmed Neurobasal A, supplemented with 2%
B27 (Life Technologies) and 0.5 mM Glutamine (Sigma, UK) for
30 min at 37C. After washing, cell release was achieved by tritura-
tion 10–15 times with a Pasteur pipette in NB-A/B27 Glutamine
medium. Progenitor cells were purified free of debris and enriched
on a two-step density OptiPrep (Axa-Shields, Oslo, Norway) gradi-
ent. Viable cells were then seeded at a density of 100,000 viable
cells per ml in NB/B27 and Glutamine directly onto poly-L-lysine
coated 24-well plates and cultured in a humidified incubator at
37C (5% CO2/95% Air). At 2 h after plating the medium was
replaced by fresh medium of NB/B27 and Glutamine or experimen-
tal condition. All media included a combined antibiotic/antimycotic
(Penicillin/Streptomycin and Fungizone, Life Tech). For cultures
longer than 3 days, two-third of the culture medium was replaced
every 3 days.
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Generation of Pure Microglial Cultures
Mixed hippocampal cells were isolated as described above. Viable cells
were plated in 1 ml/well culture medium at a density of 5 3 105
cells/ml directly onto poly-L-lysine coated six-well plates (Corning).
Two hours after plating, the cells were washed and replenished with
fresh culture medium supplemented with 10% fetal bovine serum
(FBS) and 1% antibiotic/antimycotic. After 7 days the plate was then
shaken at 1,200 rpm for 10 min followed by several hard taps on the
side and 5 s of swirling to dislodge weakly attaching cells, which are
primarily microglia. The cell suspension from several wells was pooled
and re-plated onto fresh uncoated six-well plates at a concentration of
1.5 3 105 viable cells/ml in hippocampal culture media. Cells were
allowed to attach for 1 h, after which they were washed with fresh
medium to remove FBS and weakly attached cells. Purity was deter-
mined using FITC conjugated IB4 and phase contrast imaging.
To generate microglia conditioned medium, after the purified
microglia had been incubated for 24 h in culture medium or experi-
mental condition, the medium was collected and passed through a
0.22 lm sterile filter. Microglia conditioned medium (500 ll/well)
was then added to primary hippocampal cultures at 2 h post-plating.
To generate pure microglial cell suspension for co-culture, 1
ml of warm Trypsin-EDTA was added to the freshly purified micro-
glia for 5 min at 37C. FBS (10%) was then added to inhibit any
further Trypsin activity. Cells were dislodged of the plate by triturat-
ing the cells. Cell suspension was collected and centrifuged at 1,100
rpm for 2 min. The supernatant was removed and the cell pellet re-
suspended in 3 mL of hippocampal culture medium. The process
was repeated once more. The resultant cell suspension was diluted to
1 3 105 cells/ml. Cell suspension (500 ll/well) was then added to
primary hippocampal cultures at 2 h post-plating.
Depletion of Microglia from Cultures
Microglia present in primary hippocampal neuronal cultures were selec-
tively killed using rat-MAC-SAP (Advanced Targeting Systems). MAC-
SAP is a microglia specific antibody (binds to CD11b) conjugated to
saporin (a ribosome inactivating protein). This results in only cells
expressing CD11b, namely microglia, being targeted by the toxin.
Rat-MAC-SAP (100 lg/ml), in culture medium, was added to
hippocampal neuronal cultures 2 h post-plating. Hippocampal cells
were then incubated for 24 h with the rat-MAC-SAP. At 1DIV, the
cells were washed and fresh warmed culture medium added.
Pharmacology
To examine VPAC1 and/or VPAC2 mediation of VIP effects in cul-
ture, we used the VPAC1 receptor selective agonist [Lys15, Arg16,
Leu27]-VIP (1–7)—GRF (8–27) (30 nM, Phoenix Pharmaceutical,
INC) and the VPAC1 selective antagonist [Ac-His1, D-Phe2, Lys15,
Arg16, Leu27]-VIP (3–7)-GRF (8–27) (1 lM, Phoenix Pharmaceu-
tical, INC) for the indicated times.
IL-4 Treatment and Blockade
The role of interleukin-4 in mediating the effects of VIP-treated
microglia on hippocampal progenitor cells was investigated by treat-
ing cells with 10 ng/ml purified neutralizing antibody against the
alpha subunit of the IL4 receptor (IL-4Ra) [rat-anti-mouse CD124-
(BD Pharmingen)] to block interleukin-4 activity.
To investigate the proliferative effect of interleukin-4 on hip-
pocampal progenitor cells, cells were cultured for 3DIV and for the
terminal 8 h prior to fixation, treated with 10 ng/ml recombinant
rat IL4 (R&D Systems).
Cell Death Quantification
Cell death in culture was quantified using the cell death marker pro-
pidium iodide (PI) and the nuclear stain 40,6-diamidino-2-phenylin-
dole (DAPI). PI a highly polar fluorescent dye, which is normally
excluded from healthy cells, enters dead or dying cells with leaky
membranes. Once inside the cells PI binds to nucleic acids in both
the cytoplasm and nucleus, making the cells highly fluorescent at
wavelengths of 490 nm excitation and 590 nm emission. DAPI is a
nuclear cell stain that binds to double-stranded DNA by forming a
stable fluorescent complex with a blue stain. However, DAPI is a
non-polar dye that enters both healthy (intact cell membrane) and
dying cells (damaged cell membrane). Therefore, the number of cells
stained with DAPI indicates the total number of cells in culture.
From methodological point of view, PI was added to living cells (not
fixed) in cultures at 5 lg/ml for 40 min at 37C. Cells were (while
still alive) then incubated in NB/B27 and Glutamine containing
DAPI (20 lg/ml) for another 40 min. Finally, DAPI containing
medium was removed and cells were maintained in fresh culture
medium (NB/B27 and Glutamine) while being imaged for quantifi-
cation. The proportions of non-viable cells (PI stained) of the total
(DAPI stained) cell population were then calculated.
Assessment of Cell Proliferation
In our cell culture system, we used bromodeoxyuridine (BrdU) to
measure cell proliferation. BrdU is a thymidine analog that is
incorporated into the DNA of proliferating cells during the
S-phase of the cell cycle in immunohistochemically detected
amounts (Kuhn and Cooper-Kuhn, 2007). It has been shown that
the length of the cell-cycle of progenitor cells is 12–14 h and
S-phase is estimated to correspond to a third or a half of the cell
cycle. Therefore, cells were cultured for 3DIV and 20 lM BrdU
was added to the cells for the terminal 8 h before rinsing the cells
once in PBS and then fixing them in 4% PFA for 30 min at 4C.
Immunohistochemistry could then be used to quantify BrdU
incorporation.
To study the proliferation of progenitor cells (our primary cells
of interest), we stained for BrdU and nestin (as a marker of putative
progenitor cells). An increase in the proportion of nestin-expressing
cells that incorporate BrdU (known as the mitotic index) indicates
increased proliferation of neural progenitors.
Cell proliferation was further studied using polyclonal anti-
bodies against the proliferation antigen Ki67, in combination with
BrdU. Ki-67 is an endogenous marker that is expressed by proliferat-
ing cells during active phases of the cell cycle: lateG1, G2, and M
phase, but not detectable in quiescent cells (G0 phase) (Kee et al.,
2002). Using BrdU, Ki-67, and DAPI we measured the labeling
index (cell cycle speed) and the growth fraction (recruitment of qui-
escent cells) of cells in culture.
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Immunohistochemistry
At the indicated time for each experiment, immunoflourescent stain-
ing was performed on paraformaldehyde (PFA)-fixed cells. For this
study, the following primary antibodies were used in PBS-0.1% Tri-
ton-X: rat anti-BrdU diluted 1:200 (Insight Biotechnology), mouse
anti-rat nestin diluted 1:200 (BD Biosciences), rabbit anti-GFAP
diluted 1:500 (DAKO), mouse anti-TuJ1 diluted 1:500 (Sigma), rab-
bit anti-class III-b-tubulin diluted 1:500 (Chemicon), and/or rabbit
anti-Ki67 diluted 1:500 (Novocastra). Primary antibodies were
probed using Cy2 or Cy3-conjugated anti-rat diluted 1:500, anti-
mouse diluted 1:500, and/or anti-rabbit diluted 1:200 secondary
antibodies (Jackson ImmunoResearch). Cells were then counter-
stained with the nuclear stain DAPI (5 lg/ml) (Sigma). For BrdU
immunostaining, DNA was first denatured by incubating the cells in
2 M HCl at 37C for 30 min.
Data Analysis
Imaging was performed on an inverted DM IRB microscope (Leica
Microsystems UK, Milton Keynes, UK). The area of a 203 field
was measured using a 255 lm grid graticule slide (Microbright-
field, Williston). Cell counting was performed on six random 203
fields per well using the Open Lab image-capturing system version
2.1 (Improvision, Lexington, MA). Raw data from the 203 field
counts were averaged and plotted6 SEM and expressed as cells/
mm2 per well, based on a sample of four to eight wells per condi-
tion per experiment. All experiments were repeated at least three
times. One experiment consisted of four hippocampi from two ani-
mals, pooled and prepared as described above. Data points were
plotted using GraphPad Prism data analysis software (GraphPad).
The statistical significances between the means were assessed by
either Student’s t test for single comparisons or by ANOVA fol-
lowed by post hoc tests for multiple comparisons, with P< 0.05
considered significant.
PCR Assay
For PCR, total RNA was extracted from cultured cells and directly
reverse-transcribed to complementary DNA (cDNA) using Super-
ScriptTM III Cells Direct cDNA Synthesis Kit (InvitrogenTM Life
Technologies). The cDNA was then amplified by one-step PCR kit
(rat Custom real-time PCR assay for use with SYBRgreen chemistry)
(PrimerDesign, Southampton) in a real-time thermocycler (Rotor-
Gene 6000, Corbett Robotics). The PCR reaction amplification con-
ditions were: enzyme activation for 10 min at 95C followed by
15 s for denaturation at 95C and then the data were collected in
60 s at 60C. VIP receptor primers were: VPAC1; Forward:
TAACTGAAGCGGGTGTGGAT and Reverse: CCTCTCCTAGCC
CTCAAACA. VPAC2; Forward: CGGATTTCATAGATGCGTG
TG, Reverse: CACTGTAGCCCAAGGTATA AAATG. For non-
quantitative PCR, reaction amplifications for each product were then
run on 2% agarose gel containing ethidium bromide and visualized
using UV light. To further verify gene expression in these cultures,
we used quantitative PCR where reactions were performed with
1 lL of the reconstituted primer mix, 10 lL of PrimerDesign 2X
PrecisionTM MasterMix with SYBRgreen and 4 lL PCR-Grade
water to which 25 ng/lL of the indicated (DG vs. HSVZ or con-
trol vs. VIP) cDNA was added to a final volume of 20 lL. Fluo-
rescent data were collected at once during each cycle of
amplification which allowed us for real time monitoring of the
amplification. Data were automatically normalized and a thresh-
old at was set at the level where the rate of amplification is the
greatest during the exponential phase. Ct-values were collected,
raw data were processed and analyzed using the Comparative Ct
method (Schmittgen, 2001) where the comparative expression
level equals to 22DDCt. For this method of analysis to be success-
ful, a validation experiment is required. This validation experi-
ment was performed to confirm that the amplicons performed
equally efficiently across the range of the initial template amounts
(Bustin, 2000).
Results
Microglia Are Present In Hippocampal Cultures and
Their Depletion Increases Cell Death and Reduces
NSPC Proliferation
Hippocampal progenitor cultures were generated from
postnatal rats [as described by Howell et al. (2003)] and
grown for 5DIV before being processed for the presence of
microglia, using the microglia-specific marker IB4 (Dailey
and Waite, 1999). The mean density of microglia in our
cultures was 18.89/mm2 and accounted for 11.38% of all
cells in culture (data not shown). Microglia were highly
motile and exhibited a dynamic phenotype (observed by
time-lapse photography, not shown). The majority of
microglia were amoeboid in shape reflecting an activated
phenotype supported by CD68 staining which detects
lysomes.
We next sought to examine the role of microglia in
the survival and proliferation of hippocampal progenitor
cells by depleting our cultures of microglia, using rat-
MAC-SAP (a microglia-specific antibody conjugated to the
toxin saporin). At 5DIV MAC-SAP treatment killed 85%
of endogenous microglia as demonstrated by IB4 and PI
co-staining (Fig. 1A). We found that removal of microglia
from cultures resulted in a decrease in both the number
and percentage of nestin-expressing cells by 14.816 2.25
cells/mm2 and 6.256 1.87%, respectively (Fig. 1B). The
number of GFAP expressing cells decreased by 13.196
2.65 cells/mm2, which corresponded to a decrease in the
percentage of GFAP-expressing cells of all cells 5.926
1.86% (Fig. 1C). The number of Class III-b-Tubulin
expressing cells (neurons) decreased by 10.656 1.41 cells/
mm2 and the percentage decreased by 4.936 1.31% (Fig.
1D). The decrease in cell numbers could be attributed to a
loss in trophic support as reflected by an increase in cell
death or a reduction in proliferation. Cell death was quan-
tified using the cell death marker PI and the nuclear stain
406-diamidino-2-phenylindole (DAPI) in live cell cultures
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as shown previously (Zaben et al., 2009). The percentage
of non-microglial cells that died (PI1IB42), with respect to
the total number of non-microglial cells (DAPI1IB42),
increased from 23.946 2.84% under control conditions to
36.756 3.26% when microglia were removed from culture
(Fig. 1E) indicating a trophic effect of microglia in our cell
cultures. To address effects on the proliferative population
of nestin positive NSPCs, cultures were grown for 3DIV
and pulsed with the S-phase marker BrdU for the terminal
8 h before fixation, and the mitotic index was determined.
Depletion of microglia resulted in a reduction in the
mitotic index of nestin cells from 30.486 1.81% to
20.376 2.35% (Fig. 1F).
Purified Hippocampal Microglia Are Pro-neurogenic
and Increase the Survival and Proliferation of
NSPCs
To further examine the effect of microglia, we adapted a protocol
from (Giulian and Baker, 1986) to generate 99.9% pure microglial
cultures isolated from the postnatal hippocampus (see Materials
and Methods). Adding 50,000 cells/cm2 of purified hippocampal
microglia (Fig. 2A) to hippocampal progenitor cultures resulted in
FIGURE 1: Depletion of microglia from hippocampal progenitor cell cultures results in increased cell death and reduced proliferation.
Hippocampal progenitor cell cultures were generated from postnatal rats. Cells were grown for 1DIV in the presence or absence of 100
ng/ml MAC-SAP. Cells were then washed to remove MAC-SAP and fresh medium was added. A: At 5DIV dead or dying microglia were
confirmed with IB4 and PI co-expression. B: At 5DIV total number and percentage of Nestin, C: GFAP, and D: Class III-b-Tubulin cells
were quantified in control or MAC-SAP treated conditions. E: At 5DIV, IB4, DAPI, and PI were added for the final 3 h prior to one wash
and imaging was performed. The percentage of non-microglial cells that are dead (IB42PI1/IB42DAPI1) was calculated. F: 20 lM BrdU
was added to cells at 3DIV for 8 h. Cells were then fixed and stained for BrdU and Nestin. The mitotic index (expressed as a percentage
of nestin1 cells that are also BrdU1) was calculated. *P<0.05, **P<0.01, ***P<0.001 (Student’s t-test).
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an increase in the number of nestin expressing cells from
38.366 2.78 to 71.406 3.70 cells/mm2 (95.506 17.82%
increase) (Fig. 2B). The number of GFAP-expressing cells
increased from 38.506 2.32 to 60.766 0.74 cells/mm2
(59.676 10.25% increase) (Fig. 2C). The number of Class III-b-
Tubulin-expressing cells increased from 25.486 0.93 to
35.846 1.92 cells/mm2 (40.876 7.24% increase) (Fig. 2D).
Consistent with our previous microglial depletion results, the per-
centage of non-microglial cell death relative to DAPI was reduced
from 38.576 1.08% to 28.636 0.74% when microglia were co-
cultured with hippocampal progenitors (Fig. 2E). We next studied
the effect on the proliferation of nestin-expressing progenitors and
found that the mitotic index of nestin-expressing cells increased
from 28.646 1.35% under control conditions to 42.376 0.60%
when co-cultured with microglia (Fig. 2F).
Microglia-Conditioned Medium Increases Cell
Survival and NPSC Proliferation
To see if the effects of microglia were due to released soluble
factors we applied neat filtered supernatant from the pure
FIGURE 2: Co-culture of hippocampal progenitor cells with microglia increases their survival as well as the proliferation of nestin-
expressing progenitors. A: Isolated microglia are 99.9% pure as determined using IB4 staining (scale bar525 lm). B: Purified microglial
cell suspension was added to hippocampal cultures at 2 h after plating. Cells were cultured for 5DIV and then fixed and stained for B:
nestin, C: GFAP, and D: III-b-Tubulin. E: At 5DIV DAPI, PI, and IB4 were added for 3 h, after which cells were imaged. The proportion of
non-microglial cells that are dead (IB42PI1/IB42DAPI1) was calculated. F: 20 lM BrdU was added to cells at 3DIV for 8 h. Cells were
then fixed and stained for BrdU and Nestin. The mitotic index was calculated. **P<0.01, ***P<0.001 (Student’s t-test).
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microglial cultures to microglia depleted hippocampal cul-
tures from 1DIV to 3DIV. Interestingly, the effects of micro-
glia co-culturing were consistently replicated when filtered
microglia conditioned medium was used. The number of
nestin-expressing cells increased by 35.656 3.16 cells/mm2
and the percentage increased by 12.556 2.25% (Fig. 3A).
Although the number of Class III-b-Tubulin expressing cells
increased in cultures treated with microglia conditioned
medium (by 11.116 2.21 cells/mm2), the proportion did not
increase significantly (Fig. 3B). As with our co-culture experi-
ments, cell death was significantly reduced (by
16.596 2.80%) in cultures treated with microglia condi-
tioned medium (Fig. 3C). The fact that a proportional
increase was seen in nestin-expressing cells while not in Class
III-b-Tubulin expressing cells, indicated the possibility that
microglia conditioned medium has a proliferative effect on
nestin-expressing cells. The proliferative effect on NSPCs was
confirmed by the increased mitotic index of nestin-expressing
cells from 20.706 2.54% under control conditions to
33.486 1.38% in cultures treated with microglia-conditioned
medium (Fig. 3D). We further demonstrated that treatment
of cultures with microglia-conditioned medium increased the
labeling index (BrdU/Ki67) from 0.266 0.01 to 0.366 0.01
(Fig. 3E). However, the growth fraction (Ki67/DAPI) was
FIGURE 3: Addition of microglia-conditioned medium to hippocampal progenitor cells increases cell survival and proliferation of nestin-
expressing progenitors. Microglia-conditioned medium (MGCM) was added to hippocampal cultures at 2 h after plating. At 5DIV, cells
were fixed and stained for A: nestin, B: III-b-Tubulin. Percentages of each cell phenotype with respect to the total cell count (DAPI1)
were also calculated. C: At 5DIV, DAPI and PI were added for the final 3 h prior to washing and imaging. The percentage of cells that
are dead (PI1/DAPI1) was calculated. D: The mitotic index (expressed as a percentage of nestin1 cells that are also BrdU1) was calcu-
lated by addition of 20 lM BrdU to cells at 3DIV for 8 h. Cells were then fixed and stained for BrdU and Nestin. E: At 3DIV, the growth
fraction was calculated based on the percentage of DAPI cells expressing Ki67. The labeling index was calculated by the percentage of
Ki67 cells staining for Brdu after an 8 h pulse, **P<0.01, ***P<0.001 (Student’s t-test).
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unaffected (Fig. 3E), indicating that the proliferative effect
was mediated via speeding up the cell-cycle at G1-S-phase
transition, and not through recruitment of quiescent cells.
The replication of the effects of microglia co-culture by
microglia-conditioned medium raised the possibility that
microglia exert their effect via released secondary trophic
mediators and cytokines, as the filtered supernatant was cell
free.
Pre-treating Microglia with VIP Boosts the
Proliferative and Trophic Effects of Microglia on
Hippocampal Progenitors
To test our hypothesis that VIP modulates the effect of micro-
glia on NSPCs we examined the effect of pre-treating microglia
with VIP on NSPCs by adding either VIP pre-treated or vehicle
treated microglia or their filtered supernatant to NSPC cultures.
Purified hippocampal microglia were cultured for 24 h in fresh
medium with 30 nM VIP to generate VIP-treated microglia
and filtered supernatant. We found that the number of nestin-
expressing cells increased from 66.086 1.50 cells/mm2 in cul-
tures with microglia added, to 80.786 3.82 cells/mm2 in
cultures with VIP-treated microglia added (Fig. 4A). Similarly,
cultures treated with MGCM had 55.586 3.32 nestin-
expressing cells/mm2 while those treated with VIP-treated
MGCM had 76.366 2.80 nestin-expressing cells/mm2 (Fig.
4B). The number of Class III-b-Tubulin expressing cells
increased from to by 40.876 7.24% in cultures treated with
microglia and by 71.416 7.52% in cultures with VIP-treated
microglia added (Fig. 4C). A similar result was seen with condi-
tioned medium experiments where MGCM increased the num-
ber of Class III-b-Tubulin expressing cells by 56.606 19.62%
and VIP-treated MGCM increased it by 97.26 9.48% (Fig.
4D). The trophic effect of microglia appeared to be enhanced
by pre-treatment with VIP both in co-culture and conditioned
medium experiments—cell death reduced by 6.076 1.68% in
co-culture experiments (Fig. 4E), and 7.386 1.00% in condi-
tioned medium experiments (Fig. 4F), when microglia were pre-
treated with VIP. The proliferation of nestin expressing NSPCs
(as indicated by the mitotic index after short pulse BrdU expo-
sure) also increased further in cultures exposed to VIP-treated
microglia compared with non-VIP-treated microglia (44.106
1.60% vs. 38.546 1.41%) (Fig. 4G). Similar results were
found in conditioned medium experiments (Fig. 4H).
VIPtrdMGCM significantly increased the number of Nestin-
positive GFAP-negative cells (Type 2) from 7.346 0.81 cells/
mm2 to 22.736 2.4 cells/mm2 (Fig. 4I).
VIP Acts on the VPAC1 Receptor to Boost the
Effect of Microglia on NSPC Numbers
VIP at physiological concentrations (nM) is known to act
through the high affinity receptors VPAC1 and VPAC2
receptors (Harmar et al., 1998; Zaben et al., 2009). Using
real-time PCR we have shown that VPAC1, but not VPAC2,
receptor mRNA is expressed in postnatal hippocampal micro-
glial cultures (Fig. 5A).
To investigate the involvement of VPAC1 in VIP-
microglia mediated effect, a selective VPAC1 agonist and
selective VPAC1 antagonist were used. Because of its prolifer-
ative and trophic effect, addition of MGCM to cultures
increased the total cell count (from 94.276 2.04 cells/mm2
to 128.46 3.41 cells/mm2). This effect was enhanced if
microglia were pre-treated with VIP (from 128.46 3.41 cells/
mm2 to 166.16 2.01 cells/mm2). The effect was replicated
when microglia were treated with a VPAC1 agonist in place
of VIP. Treating microglia with VIP and VPAC1 antagonist
appeared to abolish the effect of VIP pre-treatment of micro-
glia, on total cell counts (Fig. 5B).
A similar pattern of results was seen when we looked at
the numbers of nestin-expressing cells (Fig. 5C). These data
strongly suggest that VIP exerts its effects on microglia via
the VPAC1 receptor.
The VIP/MG Proliferative Effect on Hippocampal
Precursors Is IL-4 Mediated
Microglia are known to release soluble factors that affect
NSPC survival and proliferation (Cacci et al., 2008; Ekdahl
et al., 2009). IL-4 is a key immune cell derived cytokine that
can promote learning and memory (Derecki et al., 2010).
Using quantitative PCR we found that treating microglia
with 30 nM VIP resulted in a fivefold increase in mRNA
expression of interleukin-4 (Fig. 6A).
We next sought to identify the presence of the IL4
receptor (IL-4R) in our hippocampal culture system. The
expression of IL-4R mRNA was examined in hippocampal
cultures at 2 h after plating. The amplification products of
our PCR were run on 2% agarose gel stained with ethidium
bromide and then visualized with UV light. As shown (Fig.
6B), IL-4R is expressed in our hippocampal cell cultures.
The presence of IL-4R on nestin-positive cells was then
examined using immunohistochemistry. Confocal imaging
confirmed the expression of IL-4R by nestin-expressing cells
at 3DIV (Fig. 6C).
To examine the involvement of IL4 in mediating the
proliferative effect of VIP-treated microglia on nestin-
expressing cells, hippocampal cultures were treated with
microglia-conditioned medium or VIP-treated microglia-con-
ditioned medium in the presence or absence of 10 lg/ml of
IL-4Ra, a neutralizing antibody against the alpha subunit of
the IL-4 receptor which prevents IL-4 binding, and the
mitotic index was determined (no effect of an isotype control
antibody was observed, Supp Fig. 1). Blocking IL-4 activity
had no significant effect on either the total number of nestin
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FIGURE 4: The proliferative and trophic effects of microglia on hippocampal progenitors are significantly enhanced by pre-treating
microglia with VIP. Cells were cultured for 5DIV with either standard microglia or VIP (30 nM) treated microglia (24 h exposure) (A, C, E,
G). Cells were cultured for 5DIV with either standard MGCM VIPtrdMGCM (B, D, F, H and I). Cells were then fixed and stained for A
and B: nestin, C and D: III-b-Tubulin. E and F: At 5DIV IB4, DAPI and PI were added for 3 h prior to one wash and imaging was per-
formed. The proportion of non-microglial cells that are dead (IB42PI1/IB42DAPI1) was calculated (ANOVA P<0.0001). G and H: 20 lM
BrdU was added to cells at 3DIV for 8 h. Cells were then fixed and stained for BrdU and Nestin. The mitotic index (expressed as a per-
centage of nestin1 cells that are also BrdU1) was calculated. I: Nestin-positive GFAP-negative cell numbers. *P<0.05, **P<0.01,
***P<0.001 (Student’s t-test or one-way ANOVA; Bonferroni’s multiple comparison test).
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expressing cells (Fig. 6D) nor the mitotic index (Fig. 6E)
under control, VIP (30 nM), or microglia conditioned
medium conditions. However, compared with VIP-treated
MGCM, IL-4 receptor blockade reduced the number of
nestin-expressing cells from to 76.2560.64 to 54.236 1.14
cells/mm2. The mitotic index was reduced from
59.516 0.32% in cultures treated with VIP-treated MGCM
to 40.836 1.55% in cultures treated with both VIP-treated
microglia conditioned medium and the IL-4 receptor antago-
nist. Thus, the enhanced cell proliferation seen when micro-
glia are pre-treated with VIP appears to be abolished when
IL-4 receptors are blocked, suggesting that IL-4 may mediate
the proliferative effect of VIP-treated microglia on neural
progenitors.
To further determine whether IL-4 has a direct prolifer-
ative effect on nestin-expressing progenitors, we treated hip-
pocampal cultures with 10 ng/ml recombinant IL-4 and
measured the mitotic index of nestin-expressing cells. The
mitotic index increased form 31.276 1.00% under control
conditions to 51.886 0.35% under IL-4 treatment. Interest-
ingly, the mitotic index was still raised (45.666 0.40%)
when IL-4 was added to cultures treated with MAC-SAP
(i.e., depleted of microglia) indicating that IL-4 acts directly
on nestin-expressing cells rather than acting indirectly via
microglia resident in our cultures (Fig. 6F).
Taken together these findings implicate IL-4 and its
receptor system in the modulation of VIP-microglia enhanced
hippocampal progenitor cell proliferation in keeping with the
hypothesis that IL-4 is an important component in the
neuro-immuno-modulation of postnatal hippocampal
neurogenesis.
Discussion
Adult neurogenesis is important for learning and memory, is
promoted by neural activity, and is under complex regulation
by the immune system, which can be both pro and anti-
neurogenic (Deisseroth et al., 2004; Dupret et al., 2007;
Ekdahl et al., 2003; Monje et al., 2003; Shors et al., 2001;
Snyder et al., 2005; Stone et al., 2011). Microglia, the brains
resident immune cell, can either promote or inhibit the pro-
liferation of NSPCs and their differentiation into neurons
through the release of cytokines (Aarum et al., 2003; Battista
et al., 2006; Butovsky et al., 2006; Cacci et al., 2008; Ekdahl
et al., 2003; Monje et al., 2003). Our understanding of the
FIGURE 5: VIP acts on the VPAC1 receptor to increase the trophic
effect of microglia on hippocampal progenitors. A: qPCR melt
curves of VPAC1 and VPAC2 from cDNA generated from either
whole brain RNA or purified hippocampal microglia. For pharmaco-
logical studies, hippocampal progenitor cells were cultured for
5DIV under either 1: control conditions, 2: microglia-conditioned
medium, 3: VIP (30 nM) -treated microglia-condition medium, 4:
VPAC1 (30 nM) agonist-treated microglia-conditioned medium, 5:
VPAC1 (1 lM) antagonist-treated microglia condition medium, 6:
VIP (30 nM) and VPAC1 antagonist (1 lM) -treated microglia-
conditioned medium. Cells were then fixed and stained for B:
DAPI, to give total cell counts and C: nestin. *** P<0.001 (one-way
ANOVA; Bonferroni’s multiple comparison test).
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FIGURE 6: The VIP/MG proliferative effect on hippocampal precursors is IL-4 mediated. A: VIP (30 nM) induces IL-4 gene
expression in purified hippocampal microglia cells. B: Hippocampal cells express the IL-4R gene. C: Confocal images showing immuno-
staining of nestin cells co-expressing IL-4Ra. D and E: 5 DIV exposure to IL-4Ra antibody (10 lg/ml) inhibits the increase in nestin num-
bers (D) and mitotic index (E) induced by VIPtrdMGCM but not by unstimulated MGCM or direct application of VIP (30 nM) to
hippocampal cultures. F: Direct application of recombinant IL-4 (10 ng/ml) for 3DIV onto microglia depleted hippocampal cultures stimu-
lates nestin proliferation even in the absence of endogenous microglia. ***P<0.001 (one-way ANOVA; Bonferroni’s multiple comparison
test).
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interplay between neural activity, immune function and neu-
rogenesis are limited. Microglia have been shown to express a
variety of different receptors for neurotransmitters and neuro-
peptides (Pocock and Kettenmann, 2007). They have also
been postulated to respond to basal and stimulated neuronal
activity (Biber et al., 2007). Here, we show that microglia
secrete trophic and proliferative factors for NSPCs. Stimulat-
ing hippocampal microglia with the peptide neurotransmitter
VIP increases production of IL-4 which promotes their
trophic and proliferative effects on NSPCs, the latter most
likely mediated via IL-4 release. We propose a neuro-
immuno-neurogenic pathway where neuronal activity adapts
microglial control of neurogenesis by modulating their pro-
duction and release of cytokines, such as IL-4.
Microglia Release Soluble Mediators that Promote
NSPC Survival and Proliferation
The neurogenic niche is a unique environment that enables
ongoing neurogenesis to occur long into adulthood but can
be modulated in response to internal and external stimuli. As
microglia are found in neurogenic zones they are ideally
placed to influence the production of new neurons, but their
effects are complex (Ziv et al., 2006). Evidence suggests the
type and duration of stimuli are crucial in determining
whether their net effect is beneficial or detrimental to neuro-
genesis (Cacci et al., 2008). Previous studies have approached
the role of microglia in neurogenesis but have neglected to
use hippocampal microglia, which are distinct in their density
and morphology from microglia in other brain regions
(Elkabes et al., 1996; Lawson et al., 1990; Phillips et al.,
1999). As microglia from different brain regions express dif-
ferent inflammatory profiles (de Haas et al., 2008; Ren et al.,
1999), it is realistic to reason that hippocampal microglia
which exist in a specialized neurogenic niche may differ in
their abilities to regulate neurogenesis compared with micro-
glia derived from other brain regions. In our hippocampal
culture system previously used to investigate neurogenesis we
found a significant proportion of cells to be microglia
(Howell et al., 2005), but we have not previously investigated
whether they influence neurogenesis. In these hippocampal
cultures, selectively depleting endogenous microglia reduces
NSPC proliferation and survival, which results in fewer new
neurons. This was reciprocated with an increase in survival,
proliferation, and number of immature neurons following
addition of purified hippocampal microglia. As in the adult
mouse brain 70% of new neurons normally die, our data sug-
gest that microglia have the potential to reduce the amount
of immature neuron cell death and thus provide a stimulus
for increasing proliferation of the neuroblasts (Biebl et al.,
2000; Dayer et al., 2003). Microglia can release both pro and
anti-inflammatory cytokines. For example, TGF2b is released
following macrophage engulfment of apoptotic cells (Fadok
et al., 1998). However, in a co-culture model is not possible
to distinguish if the effects seen are via direct cell–cell con-
tact, phagocytosis of inhibitory debris, or via the release of
soluble mediators. To address this issue, we added microglia
conditioned media directly to NSPC cultures depleted of
microglia. Microglia conditioned media enhanced the number
and proportion of nestin, cells, and also increased TUJ1 cell
number. This suggests that hippocampal microglia release
soluble mediators that promote neurogenesis preferentially
through stimulating NSPC growth. Although it is now estab-
lished that microglia can be detrimental or beneficial to neu-
rogenesis depending on how they are activated, these studies
have focused on how the adaptive immune system or bacteri-
ally derived ligands influences microglia output (Ekdahl et al.,
2003; Monje et al., 2003). It has recently been shown that
neuronal activity can influence immune function and vice
versa (McAllister and van de Water, 2009). Therefore, we
investigated how neuropeptides, commonly found in dentate
gyrus inter-neurons innervating the neurogenic niche, can
modulate microglia’s neurogenic benefits.
VIP Augments Microglial Trophic and Proliferative
Effects via VPAC1 Receptors
VIP is a hippocampal neuropeptide localized in the CA1,
CA3, and dentate gyrus of the hippocampus (Loren et al.,
1979). Our group and others have demonstrated that VIP
can directly affect NSPC maturation (Scharf et al., 2008;
Zaben et al., 2009). It is also one of the best-studied immu-
nomodulaotry neuropeptides known to down regulate
pro-inflammatory cytokine release from LPS stimulated
microglia and enhance anti-inflammatory cytokine release
(Ganea et al., 2006; Leceta et al., 2000). Here, we show
that in addition to VIP’s direct effect on nestin positive
NSPCs (Zaben et al., 2009), simulating hippocampal micro-
glia with physiological concentrations of VIP boosts micro-
glia’s pro-neurogenic properties. VIP stimulates microglia to
release soluble mediators which enhance NSPC proliferation
(Fig. 4H) and cell survival in hippocampal cultures (Fig.
4F). We did not determine whether this trophic effect was
on all cell types or was specific to proliferating cells, but
focussed instead on the proliferative effect here. At physio-
logical concentrations, VIP can act through either VPAC1
or VPAC2 receptors. Consistent with previous studies on
macrophages and microglia our purified hippocampal micro-
glia express VPAC1 but not VPAC2 genes (Delgado et al.,
2002). Furthermore our pharmacological data support VIP’s
action to be through VPAC1. This suggests during periods
of high hippocampal activity such as learning, the release of
VIP from interneurons can have a dual effect on neurogene-
sis by directly promoting nestin positive NSPC expansion
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via VPAC2 receptors and indirectly via boosting the release
of proliferative factors from microglia through VPAC1
receptors.
VIP-Treated Microglia’s Pro-neurogenic Phenotype
Is Due to Increased IL-4 Expression and Release
Microglia can dynamically adopt different expression profiles
of cytokine and inflammatory mediators depending on the
length and type of stimuli. Although the exact profile is also
dynamic, a consensus is building toward a detrimental pro-
inflammatory and beneficial anti-inflammatory phenotype.
VIP can modify the inflammatory response of macrophages
and microglia stimulated with LPS (Delgado et al., 1999,
2003). Therefore, we sought to determine the molecular basis
of VIP’s pro-neurogenic action. In hippocampal microglia cul-
tures, VIP up-regulates IL-4 gene expression. IL-4 derived
from the adaptive immune system is important for learning
and memory by preventing development of a pro-
inflammatory phenotype (Derecki et al., 2010). In addition,
microglia expressing IL-4 are neuroprotective (Park et al.,
2005). Using a neutralizing antibody against the alpha compo-
nent of the IL-4R which blocks IL-4 binding, we show that it
had no effect on unstimulated microglia conditioned media
but blocked the additional enhancing effect of VIP-treated
microglia conditioned media. In addition, VIP also down
regulated microglia TNF2a gene expression (not shown), a
pro-inflammatory cytokine known to inhibit neurogenesis
(Liu et al., 2005). Therefore, VIP simultaneously can up-
regulate pro-neurogenic factors while down regulating anti-
neurogenic components. This data suggests that VIP, which is
released by GABAergic interneurons under specific firing con-
ditions, could influence the brains endogenous immune pro-
file to promote neurogenesis. Recent studies have confirmed
that GABAergic hilar interneurons modulate neurogenesis via
the release of GABA which both promotes the maturation of
newly born neurons (Markwardt et al., 2011) and maintains
the population of radial glia-like stem cells in a quiescent state
(Song et al., 2012). Although the latter study showed no effect
of VIP releasing interneurons on radial glia-like cells, this is
entirely consistent with our findings, as the VIP treatment of
microglia had its predominant effect on nestin positive but
GFAP-negative cells (Fig. 4I) consistent with an effect on
Type 2a (transient amplifying cells) NSPCs (Steiner et al.,
2006) which are the progeny of both themselves and of radial
glia-like NSPCs. This Type 2a cell population is also the tar-
get of the direct effects of VIP (Zaben et al., 2009) which are
non-proliferative and mediated via the VPAC2 receptor. Thus,
VIP acting directly on Type 2a cells maintains their popula-
tion pool by promoting symmetrical cell division and survival
without altering their proliferation rate. VIP also acts indi-
rectly via a VPAC1 receptor mediated effect on microglia pro-
moting increased IL-4 production and therefore increased
Type 2a NSPC proliferation to increase neurogenesis. We
have shown that these direct and indirect effects are distinct,
as VIP alone had no effect on the proliferation of nestin-
positive cells (Figs. 4H and 6E) and while IL-4R blockade did
not alter the VIP effect on nestin cells or their proliferation, it
did reduce the VIP enhancement of MGCM to that of
untreated MGCM (Fig. 6D,E). Furthermore, a significant
effect of VIP on nestin cells remained after depleting the cul-
tures of endogenous microglia (data not shown).
We found evidence of a proliferative effect of IL-4 that
is not dependant on the presence of endogenous microglia
(Fig. 6F). This may be a direct effect given our immunohisto-
chemical detection of IL-4R expression on nestin-positive cells
in culture. Although the addition of IL-4R blocking antibody
abolished the VIP/MG-mediated effect, it did not abolish the
effect of unstimulated MGCM. The enhancement of neuro-
genesis by IL-4 stimulated MG has been reported to be partly
mediated via IGF (Butovsky et al., 2006) and BDNF (Der-
ecki et al., 2010) and IL-4 may therefore have complex
effects. Interestingly, IL-4 released from meningeal T Cells
has beneficial effects on learning and memory on Morris
Water Maze testing and IL-42/2 mice exhibit severe learning
deficits [for review see Gadani et al. (2012)]. VPAC1 receptor
modulation of microglial phenotype to support hippocampal
neurogenesis may therefore be of therapeutic relevance to
conditions combining cognitive decline and neuro-
inflammation such as temporal lobe epilepsy, Alzheimer’s, and
other neurodegenerative diseases.
Conclusion
This study demonstrates a novel neuroimmune-neurogenic
pathway that may be important for promoting hippocampal
neurogenesis. We provide the first evidence that VIP, a local
circuit neuropeptide transmitter found in the dentate gyrus,
enhances the ability of microglia to increase NSPC survival
and proliferation via an IL-4 mediated mechanism.
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